The first such agent to gain U.S. Food and Drug Administration approval was Seattle Genetics Inc.
If it is approved, Seattle Genetics will market brentuximab vedotin usin a sales force of only sixty or so sales representatives in the U.S. and Canada.
FORBES: Seattle Genetics Scores Win For Smart-Bomb Cancer Drugs
Developed using technology from partner Seattle Genetics, the drug is a monoclonal antibody containing a toxic chemotherapy that attacks cancer cells if they express glycoprotein NMB, or GPNMB.
FORBES: Celldex Therapeutics Breast Cancer Drug Shows Strong Results In Some Patients
This has been a tough thing to pull off but Seattle Genetics says it has been told by the Food and Drug Administration that its study could be sufficient for an approval, despite its small size.
FORBES: Seattle Genetics Scores Win For Smart-Bomb Cancer Drugs
In a result eagerly awaited by Wall Street, drug developer Seattle Genetics announced that its experimental cancer medicine shrank tumors in 75% of patients with Hodgkin lymphoma that had relapsed despite rounds of chemotherapy and bone marrow transplants.
FORBES: Seattle Genetics Scores Win For Smart-Bomb Cancer Drugs
Among the largest underlying components of XBI, in trading today Seattle Genetics Inc ( NASD: SGEN) is up about 0.4%, Incyte Corporation ( NASD: INCY) is up about 0.8%, and Pharmacyclics, Inc. ( NASD: PCYC) is up by about 1%.
Siegall, chief executive of Seattle Genetics.
FORBES: Seattle Genetics Scores Win For Smart-Bomb Cancer Drugs
Among the largest underlying components of XBI, in trading today Seattle Genetics Incorporated ( NASD: SGEN) is up about 0.1%, Cepheid Incorporated ( NASD: CPHD) is down about 2.8%, and Alexion Pharmaceuticals Incorporated ( NASD: ALXN) is lower by about 1.7%.
FORBES: Notable ETF Outflow Detected - XBI, SGEN, CPHD, ALXN
Among the largest underlying components of XBI, in trading today Isis Pharmaceuticals, Inc. ( NASD: ISIS) is off about 0.6%, Dendreon Corp ( NASD: DNDN) is down about 3.4%, and Seattle Genetics Inc ( NASD: SGEN) is lower by about 0.9%.
Among the largest underlying components of XBI, in trading today Seattle Genetics Incorporated ( NASD: SGEN) is down about 1.4%, Alexion Pharmaceuticals Incorporated ( NASD: ALXN) is off about 0.8%, and Cubist Pharmaceuticals Incorporated ( NASD: CBST) is lower by about 0.5%.
Among the largest underlying components of IWO, in trading today CommVault Systems Inc ( NASD: CVLT) is down about 1.1%, Dril-Quip, Inc. ( NYSE: DRQ) is down about 1.1%, and Seattle Genetics Inc ( NASD: SGEN) is up by about 0.2%.
应用推荐